These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19589441)

  • 41. Ireland launches regenerative medicine research center.
    Louët S
    Nat Biotechnol; 2004 Mar; 22(3):356. PubMed ID: 15017989
    [No Abstract]   [Full Text] [Related]  

  • 42. Story Landis.
    Landis S; Mullard A
    Nat Rev Drug Discov; 2014 Oct; 13(10):718-9. PubMed ID: 25270951
    [No Abstract]   [Full Text] [Related]  

  • 43. National Heart, Lung, and Blood Institute: transitions.
    Nabel EG
    Circulation; 2009 Mar; 119(10):1453-5. PubMed ID: 19289650
    [No Abstract]   [Full Text] [Related]  

  • 44. Charting Our Future Together: Turning Discovery Science Into Cardiovascular Health.
    Gibbons GH
    Circulation; 2017 Aug; 136(7):615-617. PubMed ID: 28808143
    [No Abstract]   [Full Text] [Related]  

  • 45. Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute.
    Douglas PS; Taylor A; Bild D; Bonow R; Greenland P; Lauer M; Peacock F; Udelson J
    J Am Soc Echocardiogr; 2009 Jul; 22(7):766-73. PubMed ID: 19560655
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiovascular tissue engineering research support at the National Heart, Lung, and Blood Institute.
    Lundberg MS
    Circ Res; 2013 Apr; 112(8):1097-103. PubMed ID: 23580772
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Policy directions for the National Heart, Lung, and Blood Institute: implications for academia and industry.
    Lenfant C
    Circulation; 1985 Aug; 72(2 Pt 2):I44-7. PubMed ID: 4006158
    [No Abstract]   [Full Text] [Related]  

  • 48. Translation of genetics research to clinical medicine: the National Heart, Lung, and Blood Institute perspective.
    Puggal MA; Schully SD; Srinivas PR; Papanicolaou GJ; Jaquish CE; Fabsitz RR
    Circ Cardiovasc Genet; 2013 Dec; 6(6):634-9. PubMed ID: 24347619
    [TBL] [Abstract][Full Text] [Related]  

  • 49. On the value of portfolio diversity in heart, lung, and blood research.
    Galis ZS; Hoots WK; Kiley JP; Lauer MS
    Circ Res; 2012 Sep; 111(7):833-6. PubMed ID: 22891047
    [No Abstract]   [Full Text] [Related]  

  • 50. National Heart, Lung, and Blood Institute (NHLBI) strategic visioning: setting an agenda together for the NHLBI of 2025.
    Lauer MS; Kiley JP; Mockrin SC; Mensah GA; Hoots WK; Patel Y; Cook NL; Patterson AP; Gibbons GH
    J Am Coll Cardiol; 2015 Mar; 65(11):1130-3. PubMed ID: 25722193
    [No Abstract]   [Full Text] [Related]  

  • 51. Notes from the director of the National Heart, Lung, and Blood Institute: shaping the future of research: the NHLBI strategic plan.
    Nabel EG
    Circulation; 2007 Nov; 116(21):2479-80. PubMed ID: 18025405
    [No Abstract]   [Full Text] [Related]  

  • 52. Funding mechanisms and program management at the National Heart, Lung, and Blood Institute: confronting new challenges and exploring new opportunities.
    Shurin SB
    Circulation; 2011 Oct; 124(17):1894-6. PubMed ID: 22025639
    [No Abstract]   [Full Text] [Related]  

  • 53. Reducing Cardiovascular Disparities Through Community-Engaged Implementation Research: A National Heart, Lung, and Blood Institute Workshop Report.
    Mensah GA; Cooper RS; Siega-Riz AM; Cooper LA; Smith JD; Brown CH; Westfall JM; Ofili EO; Price LN; Arteaga S; Green Parker MC; Nelson CR; Newsome BJ; Redmond N; Roper RA; Beech BM; Brooks JL; Furr-Holden D; Gebreab SY; Giles WH; James RS; Lewis TT; Mokdad AH; Moore KD; Ravenell JE; Richmond A; Schoenberg NE; Sims M; Singh GK; Sumner AE; Treviño RP; Watson KS; Avilés-Santa ML; Reis JP; Pratt CA; Engelgau MM; Goff DC; Pérez-Stable EJ
    Circ Res; 2018 Jan; 122(2):213-230. PubMed ID: 29348251
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Research Education and Mentoring Program in Cardiovascular Diseases for Under-Represented Junior Faculty From NHLBI SIPID/PRIDE.
    Boutjdir M; Aromolaran AS; de Las Fuentes L; Boyington JEA; Arteaga SS; Jobe J; Jeffe DB; Rao DC; Rice TK; Davila-Roman VG
    J Am Coll Cardiol; 2019 Apr; 73(14):1861-1865. PubMed ID: 30975303
    [No Abstract]   [Full Text] [Related]  

  • 55. Portfolio analysis on preeclampsia and pregnancy-associated hypertension research funded by the National Heart, Lung, and Blood Institute.
    Maric-Bilkan C
    Physiol Genomics; 2018 Nov; 50(11):982-987. PubMed ID: 30265594
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Straight talk from... Colin Blakemore.
    Blakemore C
    Nat Med; 2007 Oct; 13(10):1125. PubMed ID: 17917643
    [No Abstract]   [Full Text] [Related]  

  • 57. Pulmonary research in 2013 and beyond: a National Heart, Lung, and Blood Institute perspective.
    Kiley JP; Senior RM
    Am J Physiol Lung Cell Mol Physiol; 2012 Nov; 303(9):L729-32. PubMed ID: 22962017
    [No Abstract]   [Full Text] [Related]  

  • 58. An update from the United States National Heart, Lung, and Blood Institute-funded Production Assistance for Cellular Therapies (PACT) program: a decade of cell therapy.
    Wood D; Wesselschmidt R; Hematti P; Gee AP; Rooney C; Silberstein L; Armant M; Couture L; Wagner JE; McKenna DH; Hei D; Mondoro TH; Welniak L; Lindblad R
    Clin Transl Sci; 2014 Apr; 7(2):93-9. PubMed ID: 24655892
    [No Abstract]   [Full Text] [Related]  

  • 59. Dr. Sonia Skarlatos-leader, colleague, and friend: from vascular biology to gene therapy and the Cardiovascular Cell Therapy research network.
    March KL
    Hum Gene Ther; 2013 Nov; 24(11):896-8. PubMed ID: 24164236
    [No Abstract]   [Full Text] [Related]  

  • 60. Early success claimed for Zerhouni's NIH roadmap.
    Wadman M
    Nature; 2004 Oct; 431(7011):886. PubMed ID: 15496879
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.